{
    "id": 14672,
    "fullName": "MST1R act mut",
    "impact": "unknown",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MST1R act mut indicates that this variant results in a gain of function in the Mst1r protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 4486,
        "geneSymbol": "MST1R",
        "terms": [
            "MST1R",
            "CD136",
            "CDw136",
            "NPCA3",
            "PTK8",
            "RON",
            "SEA"
        ]
    },
    "variant": "act mut",
    "createDate": "12/03/2015",
    "updateDate": "08/28/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8983,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of BKM120 and BMS-777607 (ASLAN002) inhibited tumor growth in breast cancer cell line xenograft models expressing a constitutively active short isoform of MST1R (RON), with increased efficacy over either agent alone (PMID: 26289070).",
            "molecularProfile": {
                "id": 14929,
                "profileName": "MST1R act mut"
            },
            "therapy": {
                "id": 4856,
                "therapyName": "BMS-777607 + Buparlisib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6831,
                    "pubMedId": 26289070,
                    "title": "Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26289070"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8974,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, OSI-296 inhibited tumor growth in breast cancer cell line xenograft models expressing a constitutively active short isoform of MST1R (RON) (PMID: 26289070).",
            "molecularProfile": {
                "id": 14929,
                "profileName": "MST1R act mut"
            },
            "therapy": {
                "id": 4855,
                "therapyName": "OSI-296",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6831,
                    "pubMedId": 26289070,
                    "title": "Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26289070"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8973,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BMS-777607 (ASLAN002) inhibited tumor growth in breast cancer cell line xenograft models expressing a constitutively active short isoform of MST1R (RON) (PMID: 26289070).",
            "molecularProfile": {
                "id": 14929,
                "profileName": "MST1R act mut"
            },
            "therapy": {
                "id": 687,
                "therapyName": "BMS-777607",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6831,
                    "pubMedId": 26289070,
                    "title": "Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26289070"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 14929,
            "profileName": "MST1R act mut",
            "profileTreatmentApproaches": [
                {
                    "id": 7147,
                    "name": "Zt/g4-DM1",
                    "profileName": "MST1R act mut"
                },
                {
                    "id": 7145,
                    "name": "Zt/g4",
                    "profileName": "MST1R act mut"
                },
                {
                    "id": 7148,
                    "name": "Zt/f2",
                    "profileName": "MST1R act mut"
                },
                {
                    "id": 7146,
                    "name": "Narnatumab",
                    "profileName": "MST1R act mut"
                },
                {
                    "id": 7142,
                    "name": "RON Inhibitor",
                    "profileName": "MST1R act mut"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}